Significant differences between plasma HIV-1 RNA assays in HIV-1 subtype E infected patients treated with antiretroviral therapy

Asian Pacific Journal of Allergy and Immunology

Volumn 20, Issue 2, 2002, Pages 105-111

  Ruxrungtham, Kiat ^a   Ubolyam, Sasiwimol ^a   Hassink, Elly A ^a   Ungsedhapand, Chaiwat ^a   Kroon, Eugene ^a   Duncombe, Chris ^a   Weverling, Gerrit Jan ^a   Nookai, Somboon ^a   Lange, Joep ^a   Cooper, David ^a   Phanuphak, Praphan ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; DIDANOSINE; STAVUDINE; VIRUS RNA;

ADULT; ARTICLE; ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PLASMA; SEROTYPING; THAILAND; VIRUS DETECTION; VIRUS LOAD; VIRUS TYPING;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; COHORT STUDIES; DIDANOSINE; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; MALE; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RNA, VIRAL; SELF-SUSTAINED SEQUENCE REPLICATION; SEROTYPING; STAVUDINE; THAILAND; TREATMENT OUTCOME;

EID: 0036623886     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Mellors JW, Rinaldo CRJ, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167-70.
2. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, Gupta P. Quantification of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122: 573-9.
3. Kilmarx PH, Limpakarnjanarat K, Kaewkungwal J, et al. Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand. J Infect Dis 2000; 181: 1598-606.
4. U.S. Health and Human Service. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Feb 2001. www.hivatis.org.
5. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults. JAMA. 2000; 2803: 381-91.
6. British HIV Association (BHIVA) Guidelines for Antiretroviral Treatment of HIV SeroPositive Individuals. March 2001 Draft. Available at www.aidsmap.com.
7. Ministry of Public Health, Thailand. National Guidelines for the Clinical Management of HIV Infection in Children and Adults. Sixth ed., 2000, p 57-103.
8. Coste J, Montes B, Reynes J, et al. Comparative evaluation of three assays for the quantification of human immunodeficiency virus type 1 RNA in plasma. Med Virol 1996; 50: 293-302.
9. McCutchan FE, Salminen MO, Carr JK, Burke DS. HIV-1 genetic diversity. AIDS 1996; 10: S13-S20.
10. Carr JK, Salminen MO, Koch C, et al. Full-length sequence and mosaic structure of human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996; 70: 5935-43.
11. Gao R, Robertson DL, Morrison SG, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70: 7013-29.
12. Alaeus A, Lidman K, Sonnerborg A, Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 1997; 11: 859-65.
13. Chew CB, Herring BL, Zheng F et al. Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes. J Clin Virol 1999; 14: 87-94.
14. Holguin A, de Mendoza C, Soriano V: Comparison of three different commercial methods of measuring plasma viraemia in patients infected with non-B HIV-1 subtypes: Eur J Clin Microbiol Infect Dis 1999; 18: 256-9.
15. Alaeus A, Lilja E, Herman S, et al. Assay of plasma samples representing different HIV-1 genetic subtypes: an evaluation of new versions of the Amplicor HIV-1 monitor assay. AIDS Res Hum Retroviruses 1999; 15: 889-94.
16. Michael NL, Herman SA, Kwok S, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1MONITOR test with isolates of diverse subtypes. J Clin Microbiol 1999; 37: 2557-63.
17. Nolte FS, Boysza J, Thurmond C, et al. Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 1998; 36: 716-20.
18. Murphy DG, Cote L, Fauvel M, Rene P, et al. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor. J Clin Microbiol 2000; 38: 4034-41.
19. Burgisser P, Vernazza P, Flepp M, et al. Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2000; 23: 138-44
20. Ruxrungtham K, Kroon E, Ungsedhapand C, et al. A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naïve, HIV-infected Thai patients. AIDS 2000, 14: 1375-82.
21. Ubolyam S, Ruxrungtham K, Sirivichayakul S, Okuda K, Phanuphak P. Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand. Lancet 1994; 344(8920): 485-6.
22. Segondy M, Izopet J, Pelligrin I, et al. Comparison of the Quantiplex HIV-1 RNA 2.0 assay with the Amplicor HIV-1 Monitor 1.0 assay for the quantification of levels of human immunodeficiency virus type 1 RNA in plasma of patients receiving Stavudine-Didanosine combination therapy. J Clin Microbiol 1998; 36: 3392-95.
23. Parekh B, Phillips S, Granade TC, et al. Impact of HIV type 1 subtype variation on viral RNA quantification. AIDS Res Hum Retroviruses 1999; 15: 133-42.
24. Triques K, Coste J, Perret JL, et al. Efficiency of four versions of the Amplicor HIV-1 Monitor test for quantification of different subtypes of HIV-1. J Clin Microbiol 1999; 37: 110-6.
25. Elbeik T, Charlebois E, Nassos P, et al. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5. J Clin Microbiol 2000; 38: 1113-2.
26. Schmid I, Arrer E, Hawranek T, Patsch W. Evaluation of two commercial procedures for quantification of human immunodeficiency virus type 1 RNA with respect to HIV-1 viral subtype and antiviral treatment. Clin Lab 2000; 46: 355-60.
27. Anastassopoulou CG, Touloumi G, Katsoulidou A, et al. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J Virol Methods 2001; 91: 67-74.
28. Clarke JR, Galpin S, Braganza R, et al. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients. J Med Virol 2000; 62: 445-9.